🔗 Visit the ClinicalTrials.gov page for NCT00522834
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Systematic review of medical treatment in melanoma: current status and future prospects. | Oncologist | 2011 | 2.89 |
| 2 | Redox-directed cancer therapeutics: molecular mechanisms and opportunities. | Antioxid Redox Signal | 2009 | 2.33 |
| 3 | Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. | J Clin Oncol | 2013 | 0.92 |